Science Explorer Back to mapMap
Discussion
Company · San Diego · United States

Acadia Pharmaceuticals (United States)

acadia-pharm.comROR OpenAlex
World rank, 2022-now
#21,391
of 22,385 · #28,002 all time
Rank in United States
#3,159
of 3,332
Research works
310
▲ 62% vs 2018-21
Citations
6.1k
19.5 per fractional work
Top-10% rate
7.1%
all institutions 10.0%
vs its own fields
0.92×
1.00× is exactly expected
Open access
50%
world 40%
International
26%
world 18%
Acadia Pharmaceuticals (United States)

Which fields of science does Acadia Pharmaceuticals (United States) work in?

In 2022-now, 47% of research at Acadia Pharmaceuticals (United States) is in Health Sciences, 31% in Life Sciences. Its largest fields are Medicine (42%), Biochemistry, Genetics and Molecular Biology (21%), Psychology (8%). It does 2.1× the world's share of Life Sciences.

Health Sciences: 43 fractional works · 47.4% of its workMedicine: 38 fractional works · 42.2% of its workPsychiatry and Mental health: 12 fractional works · 13.5% of its workNeurology: 11 fractional works · 12.6% of its workGenetics: 4 fractional works · 3.9% of its workPharmacology: 2 fractional works · 1.8% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 1.7% of its workSurgery: 1 fractional works · 1.4% of its workFamily Practice: 1 fractional works · 1.2% of its workPhysiology: 1 fractional works · 1.0% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 0.8% of its workComplementary and alternative medicine: 1 fractional works · 0.7% of its workOncology: 1 fractional works · 0.6% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.5% of its workGeriatrics and Gerontology: 0 fractional works · 0.5% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.5% of its workEpidemiology: 0 fractional works · 0.4% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.4% of its workSmaller subfields together: 1 fractional works · 0.8% of its workHealth Professions: 5 fractional works · 5.2% of its workPhysical Therapy, Sports Therapy and Rehabilitation: 1 fractional works · 1.5% of its workHealth Information Management: 1 fractional works · 1.1% of its workOccupational Therapy: 1 fractional works · 1.1% of its workSpeech and Hearing: 1 fractional works · 1.0% of its workGeneral Health Professions: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.0% of its workLife Sciences: 28 fractional works · 30.8% of its workBiochemistry, Genetics and Molecular Biology: 19 fractional works · 21.0% of its workGenetics: 10 fractional works · 11.4% of its workMolecular Biology: 8 fractional works · 8.5% of its workBiochemistry: 0 fractional works · 0.5% of its workCell Biology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 6 fractional works · 6.8% of its workCognitive Neuroscience: 2 fractional works · 2.5% of its workCellular and Molecular Neuroscience: 2 fractional works · 2.4% of its workBiological Psychiatry: 1 fractional works · 1.0% of its workNeurology: 1 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.4% of its workPharmacology: 1 fractional works · 0.7% of its workPharmaceutical Science: 1 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 1 fractional works · 1.2% of its workAnimal Science and Zoology: 0 fractional works · 0.5% of its workPlant Science: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 0 fractional works · 0.2% of its workImmunology: 0 fractional works · 0.2% of its workSocial Sciences: 15 fractional works · 16.6% of its workPsychology: 8 fractional works · 8.3% of its workClinical Psychology: 6 fractional works · 6.8% of its workSocial Psychology: 1 fractional works · 0.7% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workSocial Sciences: 5 fractional works · 5.8% of its workSociology and Political Science: 2 fractional works · 2.6% of its workEducation: 1 fractional works · 0.7% of its workHealth: 0 fractional works · 0.5% of its workDemography: 0 fractional works · 0.4% of its workLaw: 0 fractional works · 0.4% of its workPolitical Science and International Relations: 0 fractional works · 0.4% of its workUrban Studies: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.5% of its workArts and Humanities: 1 fractional works · 1.3% of its workHistory: 1 fractional works · 1.1% of its workPhilosophy: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.0% of its workEconomics and Econometrics: 1 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 0 fractional works · 0.1% of its workPhysical Sciences: 5 fractional works · 5.3% of its workEnvironmental Science: 2 fractional works · 2.3% of its workEcology: 1 fractional works · 1.0% of its workGlobal and Planetary Change: 1 fractional works · 0.9% of its workManagement, Monitoring, Policy and Law: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEarth and Planetary Sciences: 2 fractional works · 1.7% of its workGeology: 1 fractional works · 0.7% of its workGeochemistry and Petrology: 0 fractional works · 0.5% of its workAtmospheric Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workComputer Science: 1 fractional works · 0.7% of its workInformation Systems: 0 fractional works · 0.4% of its workArtificial Intelligence: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEngineering: 0 fractional works · 0.4% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.1% of its workALL ITS WORKAcadiaPharmaceuticals…91fractional works, 2022-now
Life Sciences31%Physical Sciences5%Health Sciences47%Social Sciences17%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 18 fields, with their numbers
    1. Medicine3842.2%
    2. Health Professions55.2%
    1. Biochemistry, Genetics and Molecular Biology1921.0%
    2. Neuroscience66.8%
    3. Pharmacology, Toxicology and Pharmaceutics11.4%
    4. Agricultural and Biological Sciences11.2%
    5. Immunology and Microbiology00.2%
    1. Psychology88.3%
    2. Social Sciences55.8%
    3. Arts and Humanities11.3%
    4. Economics, Econometrics and Finance11.0%
    5. Business, Management and Accounting00.1%
    1. Environmental Science22.3%
    2. Earth and Planetary Sciences21.7%
    3. Computer Science10.7%
    4. Engineering00.4%
    5. Chemistry00.1%
    6. Physics and Astronomy00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.26× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.94× its world share, 19 worksBiochemistry, Geneti…Immunology and Microbiology: 0.24× its world share, 0 worksImmunology and Micro…Neuroscience: 4.22× its world share, 6 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.99× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.05× its world share, 0 worksChemistryComputer Science: 0.09× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 1.09× its world share, 2 worksEarth and Planetary …Engineering: 0.03× its world share, 0 worksEngineeringEnvironmental Science: 0.46× its world share, 2 worksEnvironmental SciencePhysics and Astronomy: 0.03× its world share, 0 worksPhysics and AstronomyHealth Professions: 1.97× its world share, 5 worksHealth ProfessionsMedicine: 2.20× its world share, 38 worksMedicineArts and Humanities: 0.45× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 0.03× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.47× its world share, 1 worksEconomics, Econometr…Psychology: 2.73× its world share, 8 worksPsychologySocial Sciences: 0.46× its world share, 5 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 4.2×. Every wedge is a field page.

All 18 fields, with their numbers
  1. Neuroscience4.22×6 works
  2. Pharmacology, Toxicology and Pharmaceutics3.99×1 works
  3. Biochemistry, Genetics and Molecular Biology3.94×19 works
  4. Psychology2.73×8 works
  5. Medicine2.20×38 works
  6. Health Professions1.97×5 works
  7. Earth and Planetary Sciences1.09×2 works
  8. Economics, Econometrics and Finance0.47×1 works
  9. Environmental Science0.46×2 works
  10. Social Sciences0.46×5 works
  11. Arts and Humanities0.45×1 works
  12. Agricultural and Biological Sciences0.26×1 works
  13. Immunology and Microbiology0.24×0 works
  14. Computer Science0.09×1 works
  15. Chemistry0.05×0 works
  16. Engineering0.03×0 works
  17. Physics and Astronomy0.03×0 works
  18. Business, Management and Accounting0.03×0 works

Who are the top researchers at Acadia Pharmaceuticals (United States)?

Ranked on the quality score, James M. Youakim, Mark R. Brann and Douglas W. Bonhaus lead among researchers whose main affiliation is Acadia Pharmaceuticals (United States).

  1. 1 James M. Youakim United States · #431,938 worldwide 2.1k citations · 61 works
  2. 2 Mark R. Brann United States · #608,994 worldwide 12k citations · 125 works
  3. 3 Douglas W. Bonhaus United States · #727,770 worldwide 4.7k citations · 101 works
  4. 4 Roger Mills United States · #794,068 worldwide 4.8k citations · 30 works
  5. 5 Krista McFarland United States · #850,885 worldwide 6.4k citations · 45 works
  6. 6 Andria Lee Del Tredici United States · #950,569 worldwide 1.5k citations · 39 works
  7. 7 Bradley W. McEvoy United States · #1,309,853 worldwide 2.5k citations · 27 works
  8. 8 David M. Weiner United States · #1,733,363 worldwide 5.1k citations · 129 works
  9. 9 Hilde Williams United States · #1,881,263 worldwide 2.7k citations · 35 works
  10. 10 Srdjan Stankovic United States · #1,937,974 worldwide 494 citations · 15 works
All ranked researchers at Acadia Pharmaceuticals (United States)

What are the most cited papers from Acadia Pharmaceuticals (United States)?

The most cited paper from Acadia Pharmaceuticals (United States) is "BART: Bayesian Additive Regression Trees" (Hugh Chipman, Edward I. George, Robert E. McCulloch, 2006), with 969 citations. Next come "Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial" (955) and "A new glucagon and GLP-1 co-agonist eliminates obesity in rodents" (645).

Most cited papers
#PaperReleasedCitations
1 BART: Bayesian Additive Regression Trees Hugh Chipman, Edward I. George, Robert E. McCulloch · ScholarlyCommons (University of Pennsylvania) Open access 2006 969
2 Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial Jeffrey L. Cummings, Stuart Isaacson, Roger Mills et al. · The Lancet 31 Oct 2013 955
3 A new glucagon and GLP-1 co-agonist eliminates obesity in rodents Jonathan W. Day et al. · Nature Chemical Biology Open access 13 Jul 2009 645
4 A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents Brian Finan et al. · Nature Medicine Open access 8 Dec 2014 643
5 Control of cell cycle progression by c-Jun is p53 dependent Martin J. Schreiber, Andrea Kolbus, Fabrice Piu et al. · Genes & Development Open access Mar 1999 583
All 60 most cited papers, with filters and sorting

Which keywords describe research at Acadia Pharmaceuticals (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Parkinson's Disease, Oxidative Stress, Neurodegeneration, Mitochondrial Dysfunction, Genetic Mutations, Dendritic Spines, Diagnostic Criteria and Brain Development.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Oxidative Stress12▲ 8.2×5 topics
  2. Parkinson's Disease12▲ 55×5 topics
  3. Mitochondrial Dysfunction11▲ 42×4 topics
  4. Neurodegeneration11▲ 41×5 topics
  5. Genetic Mutations11▲ 27×4 topics
  6. Dendritic Spines10▲ 147×2 topics
  7. Diagnostic Criteria10▲ 48×2 topics
  8. Brain Development10▲ 61×2 topics
  9. Fragile X Syndrome10▲ 390×1 topic
  10. Rett Syndrome10▲ 390×1 topic
  11. Dopaminergic Neurons10▲ 164×1 topic
  12. a-Synuclein10▲ 202×1 topic
  13. Cognitive Therapy5▲ 48×2 topics
  14. Metabolic Syndrome5▲ 6.6×2 topics
  15. Antipsychotic Drugs5▲ 133×1 topic
  16. Autism Spectrum Disorders5▲ 52×2 topics
  17. Neurocognitive Deficits5▲ 133×1 topic
  18. Alzheimer's Disease4▲ 17×5 topics
  19. Coping Strategies4▲ 18×2 topics
  20. Neuroimaging4▲ 15×4 topics
  21. Resilience4▲ 8.5×2 topics
  22. Caregiver Well-Being4▲ 77×1 topic
  23. Parenting Stress4▲ 59×1 topic
  24. Feeding Problems4▲ 103×1 topic
  25. Neurological Disorders4▲ 6.7×9 topics
  26. SMN14▲ 177×1 topic
  27. Sensory Sensitivity4▲ 103×1 topic
  28. Spinal Muscular Atrophy4▲ 177×1 topic
  29. Genetics3▲ 5.2×6 topics
  30. Aging3▲ 5.6×3 topics
  31. Pharmacology3▲ 12×2 topics
  32. Deep Brain Stimulation2▲ 39×3 topics
  33. Neurobiology2▲ 11×6 topics
  34. Caregiver Burden2▲ 22×2 topics
  35. Neurodegenerative Diseases2▲ 15×3 topics
  36. Schizophrenia2▲ 22×3 topics
  37. Crystal Structure2▲ 17×2 topics
  38. Elderly2▲ 9.5×3 topics
  39. Dementia2▲ 23×2 topics
  40. Toxicology2▲ 13×4 topics

Which research topics does Acadia Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Genetics and Neurodevelopmental Disorders, Parkinson's Disease Mechanisms and Treatments, Schizophrenia research and treatment and Family and Disability Support Research.

Genetics and Neurodevelo…10Genetics and Neurodevelopmental Disorders: 10 fractional worksParkinson's Disease Mech…10Parkinson's Disease Mechanisms and Treatments: 10 fractional worksSchizophrenia research and treatment: 5 fractional worksFamily and Disability Support Research: 4 fractional worksChild Nutrition and Feeding Issues: 4 fractional worksNeurogenetic and Muscula…4Neurogenetic and Muscular Disorders Research: 4 fractional worksDementia and Cognitive Impairment Research: 2 fractional worksCholinesterase and Neurodegenerative Diseases: 1 fractional worksBalance, Gait, and Falls Prevention: 1 fractional worksReceptor Mechanisms and Signaling: 1 fractional works
GeneticsNeurologyPsychiatry and Mental healthClinical Psychology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Genetics and Neurodevelopmental Disorders Genetics 10 works
  2. 2 Parkinson's Disease Mechanisms and Treatments Neurology 10 works
  3. 3 Schizophrenia research and treatment Psychiatry and Mental health 5 works
  4. 4 Family and Disability Support Research Clinical Psychology 4 works
  5. 5 Child Nutrition and Feeding Issues Psychiatry and Mental health 4 works
  6. 6 Neurogenetic and Muscular Disorders Research Genetics 4 works
  7. 7 Dementia and Cognitive Impairment Research Psychiatry and Mental health 2 works
  8. 8 Cholinesterase and Neurodegenerative Diseases Pharmacology 1 works
  9. 9 Balance, Gait, and Falls Prevention Physical Therapy, Sports Therapy and Rehabilitation 1 works
  10. 10 Receptor Mechanisms and Signaling Molecular Biology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.6%not open50.4%

World: 40% of research is openly available.

with international co-authors26.2%domestic only73.8%

World: 18% is written across borders.

How has Acadia Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 62% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Acadia Pharmaceuticals (United States) as a percentage of every work published that year, 0.00037% in 2024.

still counting0.00025%0.00050%0.00075%Acadia Pharmaceuticals (United States)0.00044% in 202519801990200020102020

Fractional works of Acadia Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in San Diego

All research institutions in San Diego

Share Acadia Pharmaceuticals (United States)'s ranking

Acadia Pharmaceuticals (United States) on Science Explorer

A card with Acadia Pharmaceuticals (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Acadia Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.